Press Releases

Genovis AB, developer and manufacturer of tools for transfection and antibody-engineering, has agreed to a one-year marketing collaboration with its US distributor – Bulldog Bio Inc. The agreement broadens an existing arrangement allowing for more extensive branding of Genovis’ products through marketing-based channels.

Ella Fontaine, Vice President of Communications at Bulldog Bio stated, “The innovative products provided by Genovis have an elegant story that will resonate with the US research community. We are pleased with the response to our unique, cost-sharing model, for marketing – and we look forward to advancing the awareness of Genovis’ brand here in the US.”

Bridge Bioscience Inc. has completed the transfer of all assets and intellectual property associated with the business to Bulldog Bio Incorporated. Bridge Bioscience has been manufacturing and providing high quality electroporation cuvettes for over eight years. These disposables are used for the delivery of DNA and RNA into a variety of eukaryotic and prokaryotic cells. With this purchase Bulldog Bio will complement their existing lines of transfection products and establish a manufacturing base for the company.

Ella Fontaine, Vice President of Communications at Bulldog Bio stated “The business model developed by Bridge of offering direct from manufacturer pricing, will allow Bulldog Bio to continue to provide these quality products at a very affordable level.” She further remarked “Bridge Bioscience has always run as a profitable business and it is our intent to maintain the current sales channel. We will look to develop growth in new markets in which the Bridge Electroporation Cuvettes are currently not being sold.”

Q.Instruments GmbH has offered its best selling line of mixing and incubation equipment, the BioShake series, to Bulldog Bio Inc. for distribution in the US. The partnership will provide Q.Instruments with a strong sales channel to deliver its patented lines of plate shakers and thermomixers to the US research community. Q.Instruments has already established the BioShake as a strong competitor in Europe, and is now looking to establish its brand in the US. Ella Fontaine, Vice President of Communications at Bulldog Bio stated: “This is another feather in our cap, as Bulldog looks to add compelling products that can generate excitement amongst researchers in the US. We look forward to using our extensive set of marketing tools to raise the brand awareness of the BioShake line.”

Genovis provides novel technical solutions for Transfection, RNAi, Imaging and Antibody Engineering for customers involved in sophisticated research in the pharmaceutical industry and academic research community.

For two years the fully owned subsidiary Genovis Inc. has consistently built sales channels in the US. During this period several distribution agreements have been entered, and Genovis has thus decided to close down its subsidiary and to work only through distributors and collaborators in the US market.

”This distribution agreement is an important step for Genovis as we expand into the North American market. The agreement broadens our presence and increases the exposure of our trademark. I am pleased with the opportunities this represents and I look forward to working with Bulldog Bio and their efficient and experienced team”, says Sarah Fredriksson, CEO Genovis AB.

Bulldog Bio is committed to growing the market share and revenue of its partners’ product lines in the US Life Science research community. Brand building, technical expertise and world-class support are the foundation of Bulldog Bio’s business model. The company employees have broad competence in Genovis’ business areas and pride themselves on efficient service and effective marketing.

Bulldog Bio Inc. and Medline Inc. agree to an alliance for bringing Medline's flagship line of Labcare products to the life science market place. Bulldog Bio will market and sell Aloetouch and Remedy branded lines directly to the research community. "It is our belief that these lines will offer the pinnacle for improving the personal satisfaction of any bench researcher. We are surprised that these market-leading products haven't already made their way into research laboratories. And we feel fortunate to be the first to offer them to US scientific community."